The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Open accessAbstract
Increasing antimalarial drug resistance once again threatens effective antimalarial drug treatment, malaria control, and elimination. Artemisinin combination therapies (ACTs) are first-line treatment for uncomplicated falciparum malaria in all endemic countries, yet partial resistance to artemisinins has emerged in the Greater Mekong Subregion. Concomitant emergence of partner drug resistance is now causing high ACT treatment failure rates in several areas. Genetic markers for artemisinin resistance and several of the partner drugs have been established, greatly facilitating surveillance. Single point mutations in the gene coding for the Kelch propeller domain of the K13 protein strongly correlate with artemisinin resistance. Novel regimens and strategies using existing antimalarial drugs will be needed until novel compounds can be deployed. Elimination of artemisinin resistance will imply elimination of all falciparum malaria from the same areas. In vivax malaria, chloroquine resistance is an increasing problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Malaria Parasites in Continuous Culture
Trager, W., & Jensen, J. B. (1976) · Science · doi:10.1126/science.781840 · Cited by 7,844
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Self-citationThe effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., Dalrymple, U., Battle, K. E., Moyes, C. L., Henry, A., Eckhoff, P. A., et al. (2015) · Nature · doi:10.1038/nature15535 · Cited by 3,225
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique
Desjardins, R. E., Canfield, C. J., Haynes, J. D., & Chulay, J. D. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.6.710 · Cited by 2,514
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
Self-citationA molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., & Fukuda, M. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805011 · Cited by 1,785
White, N. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421682 · Cited by 1,248
Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening
Smilkstein, M., Sriwilaijaroen, N., Kelly, J. X., Wilairat, P., & Riscoe, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1803-1806.2004 · Cited by 1,210
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
Qinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60484-x · Cited by 924
Self-citationK13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Straimer, J., Gnädig, N. F., Witkowski, B., Amaratunga, C., Duru, V., Ramadani, A. P., Dacheux, M., Khim, N., Zhang, L., Lam, S., et al. (2015) · Science · doi:10.1126/science.1260867 · Cited by 728
Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system
Ghorbal, M., Gorman, M., Macpherson, C. R., Martins, R. M., Scherf, A., & Lopez-Rubio, J.-J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2925 · Cited by 653
Oxidative stress in malaria parasite-infected erythrocytes: host–parasite interactions
Becker, K., Tilley, L., Vennerstrom, J. L., Roberts, D., Rogerson, S., & Ginsburg, H. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2003.09.011 · Cited by 652
Artemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
Self-citationWitkowski, B., Amaratunga, C., Khim, N., Sreng, S., Chim, P., Kim, S., Lim, P., Mao, S., Sopha, C., Sam, B., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70252-4 · Cited by 629
Self-citationGenetic architecture of artemisinin-resistant Plasmodium falciparum
Miotto, O., Amato, R., Ashley, E. A., MacInnis, B., Almagro-Garcia, J., Amaratunga, C., Lim, P., Mead, D., Oyola, S. O., Dhorda, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3189 · Cited by 609
Self-citationA molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
Mbengue, A., Bhattacharjee, S., Pandharkar, T., Liu, H., Estiu, G., Stahelin, R. V., Rizk, S. S., Njimoh, D. L., Ryan, Y., Chotivanich, K., et al. (2015) · Nature · doi:10.1038/nature14412 · Cited by 597
Self-citationMakler, M. T., & Hinrichs, D. J. (1993) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.48.205 · Cited by 559
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
Ménard, D., Khim, N., Beghain, J., Adegnika, A. A., Shafiul-Alam, M., Amodu, O., Rahim-Awab, G., Barnadas, C., Berry, A., Boum, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513137 · Cited by 551
Fry, M., & Pudney, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90213-3 · Cited by 529
The public health impact of chloroquine resistance in Africa
Trape, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.12 · Cited by 521
PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
Rieckmann, K. H., Davis, D. R., & Hutton, D. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91792-3 · Cited by 501
Amaratunga, C., Lim, P., Suon, S., Sreng, S., Mao, S., Sopha, C., Sam, B., Dek, D., Try, V., Amato, R., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00487-9 · Cited by 493
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
Miotto, O., Almagro-Garcia, J., Manske, M., MacInnis, B., Campino, S., Rockett, K. A., Amaratunga, C., Lim, P., Suon, S., Sreng, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2624 · Cited by 462
Self-citationImpact of chloroquine resistance on malaria mortality
Trape, J.-F., Pison, G., Preziosi, M.-P., Enel, C., du Loû, A. D., Delaunay, V., Samb, B., Lagarde, E., Molez, J.-F., & Simondon, F. (1998) · Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(98)80009-7 · Cited by 452
Mok, S., Ashley, E. A., Ferreira, P. E., Zhu, L., Lin, Z., Yeo, T., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Dhorda, M., et al. (2015) · Science · doi:10.1126/science.1260403 · Cited by 435
Self-citationMalaria medicines: a glass half full?
Wells, T. N. C., van Huijsduijnen, R. H., & Van Voorhis, W. C. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4573 · Cited by 430
Takala-Harrison, S., Jacob, C. G., Arze, C., Cummings, M. P., Silva, J. C., Dondorp, A. M., Fukuda, M. M., Hien, T. T., Mayxay, M., Noedl, H., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu491 · Cited by 422
Self-citationTun, K. M., Imwong, M., Lwin, K. M., Win, A. A., Hlaing, T. M., Hlaing, T., Lin, K., Kyaw, M. P., Plewes, K., Faiz, M. A., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70032-0 · Cited by 414
Self-citationGlobal extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Price, R. N., von Seidlein, L., Valecha, N., Nosten, F., Baird, J. K., & White, N. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70855-2 · Cited by 388
Loraine, J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)93011-6 · Cited by 357
Amaratunga, C., Sreng, S., Suon, S., Phelps, E. S., Stepniewska, K., Lim, P., Zhou, C., Mao, S., Anderson, J. M., Lindegardh, N., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70181-0 · Cited by 344
Self-citationDelvenne, J. (2019) · Digital Commons@Becker (Washington University School of Medicine) · doi:10.1016/s1473-3099 · Cited by 329
Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
Dogovski, C., Xie, S. C., Burgio, G., Bridgford, J., Mok, S., McCaw, J. M., Chotivanich, K., Kenny, S., Gnädig, N., Straimer, J., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002132 · Cited by 327
Self-citationIncreased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence Mechanism
Witkowski, B., Lelièvre, J., López Barragán, M. J., Laurent, V., Su, X.-Z., Berry, A., & Benoit-Vical, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01636-09 · Cited by 317
Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia
Witkowski, B., Khim, N., Chim, P., Kim, S., Ke, S., Kloeung, N., Chy, S., Duong, S., Leang, R., Ringwald, P., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01868-12 · Cited by 308
Self-citationAntimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network
Cui, L., Mharakurwa, S., Ndiaye, D., Rathod, P. K., & Rosenthal, P. J. (2015) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0007 · Cited by 305
Leang, R., Taylor, W. R. J., Bouth, D. M., Song, L., Tarning, J., Char, M. C., Kim, S., Witkowski, B., Duru, V., Domergue, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00835-15 · Cited by 302
Self-citationRelapses of Plasmodium vivax Infection Usually Result from Activation of Heterologous Hypnozoites
Imwong, M., Snounou, G., Pukrittayakamee, S., Tanomsing, N., Kim, J. R., Nandy, A., Guthmann, J., Nosten, F., Carlton, J., Looareesuwan, S., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512241 · Cited by 294
Flegg, J. A., Guerin, P. J., White, N. J., & Stepniewska, K. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-339 · Cited by 285
Taylor, S. M., Parobek, C. M., DeConti, D. K., Kayentao, K., Coulibaly, S. O., Greenwood, B. M., Tagbor, H., Williams, J., Bojang, K., Njie, F., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu467 · Cited by 283
K13-Propeller Polymorphisms in Plasmodium falciparum Parasites From Sub-Saharan Africa
Kamau, E., Campino, S., Amenga-Etego, L., Drury, E., Ishengoma, D., Johnson, K., Mumba, D., Kekre, M., Yavo, W., Mead, D., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu608 · Cited by 258
Korenromp, E. L., Williams, B. G., Gouws, E., Dye, C., & Snow, R. W. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00657-1 · Cited by 245
Jiménez-Díaz, M. B., Ebert, D., Salinas, Y., Pradhan, A., Lehane, A. M., Myrand-Lapierre, M.-E., O’Loughlin, K. G., Shackleford, D. M., Justino de Almeida, M., Carrillo, A. K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414221111 · Cited by 245
Spring, M. D., Lin, J. T., Manning, J. E., Vanachayangkul, P., Somethy, S., Bun, R., Se, Y., Chann, S., Ittiverakul, M., Sia-ngam, P., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70049-6 · Cited by 244
Dihydroartemisinin–Piperaquine Failure in Cambodia
Saunders, D. L., Vanachayangkul, P., & Lon, C. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1403007 · Cited by 225
Fivelman, Q. L., Butcher, G. A., Adagu, I. S., Warhurst, D. C., & Pasvol, G. (2002) · Malaria Journal · doi:10.1186/1475-2875-1-1 · Cited by 225
Altered temporal response of malaria parasites determines differential sensitivity to artemisinin
Klonis, N., Xie, S. C., McCaw, J. M., Crespo-Ortiz, M. P., Zaloumis, S. G., Simpson, J. A., & Tilley, L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217452110 · Cited by 213
Birth, D., Kao, W.-C., & Hunte, C. (2014) · Nature Communications · doi:10.1038/ncomms5029 · Cited by 205
Duru, V., Khim, N., Leang, R., Kim, S., Domergue, A., Kloeung, N., Ke, S., Chy, S., Eam, R., Khean, C., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0539-5 · Cited by 197
Self-citationHyperparasitaemia and low dosing are an important source of anti-malarial drug resistance
White, N. J., Pongtavornpinyo, W., Maude, R. J., Saralamba, S., Aguas, R., Stepniewska, K., Lee, S. J., Dondorp, A. M., White, L. J., & Day, N. P. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-253 · Cited by 194
Self-citationANTIGLUCOCORTICOID ACTIONS OF DEHYDROEPIANDROSTERONE AND LOW CONCENTRATIONS IN ALZHEIMER'S DISEASE
Svec, F., & Lopez-S, A. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91940-5 · Cited by 192
Carrara, V. I., Lwin, K. M., Phyo, A. P., Ashley, E., Wiladphaingern, J., Sriprawat, K., Rijken, M., Boel, M., McGready, R., Proux, S., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001398 · Cited by 185
Leang, R., Barrette, A., Bouth, D. M., Menard, D., Abdur, R., Duong, S., & Ringwald, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00686-12 · Cited by 185
Self-citationHistidine-Rich Protein II: a Novel Approach to Malaria Drug Sensitivity Testing
Noedl, H., Wernsdorfer, W. H., Miller, R. S., & Wongsrichanalai, C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1658-1664.2002 · Cited by 184
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
Maude, R. J., Pontavornpinyo, W., Saralamba, S., Aguas, R., Yeung, S., Dondorp, A. M., Day, N. P., White, N. J., & White, L. J. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-31 · Cited by 184
Self-citationRaj, D. K., Mu, J., Jiang, H., Kabát, J., Singh, S., Sullivan, M., Fay, M. P., McCutchan, T. F., & Su, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806944200 · Cited by 163
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
Saralamba, S., Ngum, W. P., Maude, R. J., Lee, S. J., Tärning, J., Lindegårdh, N., Chotivanich, K., Nosten, F. H., Day, N. P. J., Socheat, D., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006113108 · Cited by 162
Self-citationHuang, F. J., Takala‐Harrison, S., Jacob, C. G., Liu, H., Sun, X., Yang, H., Nyunt, M. M., Adams, M., Zhou, S., Xia, Z., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv249 · Cited by 149
In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam
Hien, T. T., Nguyen, T.-N., Phu, N. H., Boni, M. F., Thanh, N. V., Nha-Ca, N. T., Thai, L. H., Thai, C. Q., Toi, P. V., Thuan, P. D., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-355 · Cited by 143
Vaidya, A. B., Morrisey, J. M., Zhang, Z., Das, S., Daly, T. M., Otto, T. D., Spillman, N. J., Wyvratt, M. J., Siegl, P. K. S., Marfurt, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6521 · Cited by 136
Conrad, M. D., Bigira, V., Kapisi, J., Muhindo, M. K., Kamya, M. R., Havlir, D. V., Dorsey, G., & Rosenthal, P. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105690 · Cited by 130
Antimalarial drug resistance in Africa: key lessons for the future
Takala‐Harrison, S., & Laufer, M. K. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12766 · Cited by 127
Sulfadoxine-pyrimethamine pharmacokinetics in malaria: Pediatric dosing implications
Barnes, K. I., Little, F., SMITH, P., Evans, A. M., Watkins, W. M., & White, N. J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.08.016 · Cited by 126
High recombination rates and hotspots in a Plasmodium falciparum genetic cross
Jiang, H., Li, N., Gopalan, V., Zilversmit, M. M., Varma, S., Nagarajan, V., Li, J., Mu, J., Hayton, K., Henschen, B., et al. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r33 · Cited by 126
Bacon, D., Latour, C., Lucas, C. M., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01313-06 · Cited by 125
Spillman, N. J., & Kirk, K. (2015) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2015.07.001 · Cited by 125
Access to artemisinin combination therapy for malaria in remote areas of Cambodia
Yeung, S., Damme, W. V., Socheat, D., White, N. J., & MILLS, A. J. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-96 · Cited by 119
Barnes, K. I., & White, N. J. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.014 · Cited by 118
Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression
Nagard, H. L., Vincent, C., Mentré, F., & Bras, J. L. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.08.003 · Cited by 118
Barnes, K. I., Little, F., Mabuza, A. M., Mngomezulu, N., Govere, J. M., Dürrheim, D. N., Roper, C., Watkins, B., & White, N. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/587645 · Cited by 118
Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013
Madamet, M., Fall, B., Benoît, N., Camara, C., Amalvict, R., Fall, M., Dionne, P., Fall, K. B., Nakoulima, A. D., Diatta, B., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-472 · Cited by 110
Plasmodium falciparum pfmdr1 Amplification, Mefloquine Resistance, and Parasite Fitness
Preechapornkul, P., Imwong, M., Chotivanich, K., Ngum, W. P., Dondorp, A. M., Day, N., White, N. J., & Pukrittayakamee, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00241-08 · Cited by 107
Self-citationArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria
Gogtay, N., Kannan, S., Thatte, U. M., Olliaro, P., & Sinclair, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008492.pub3 · Cited by 101
Direct evidence for the atovaquone action on the Plasmodium cytochrome bc 1 complex
Siregar, J. E., Kurisu, G., Kobayashi, T., Matsuzaki, M., Sakamoto, K., Mi‐ichi, F., Watanabe, Y.-I., Hirai, M., Matsuoka, H., Syafruddin, D., et al. (2014) · Parasitology International · doi:10.1016/j.parint.2014.09.011 · Cited by 100
Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum
Cui, L., Wang, Z., Miao, J., Miao, M., Chandra, R., Jiang, H., Su, X., & Cui, L. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08180.x · Cited by 100
Verdrager, J. (1986) · PubMed · Cited by 83
Counterfeit artesunate antimalarials in southeast Asia
Newton, P. N., Dondorp, A. M., Green, M., Mayxay, M., & White, N. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13872-x · Cited by 76
Self-citationLopera-Mesa, T. M., Doumbia, S., Chiang, S., Zeituni, A. E., Konate, D. S., Doumbouya, M., Keita, A. S., Stepniewska, K., Traoré, K., Diakité, S. A. S., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit082 · Cited by 74
Stepniewska, K., & White, N. J. (2006) · Malaria Journal · doi:10.1186/1475-2875-5-127 · Cited by 72
Teuscher, F., Chen, N., Kyle, D. E., Gatton, M. L., & Cheng, Q. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05456-11 · Cited by 71
Kinetic characterization of Na+/H+ antiport of Plasmodium falciparum membrane
Bosìa, A., Ghigo, D., Turrini, F. M., Nissani, E., Pescarmona, G., & Ginsburg, H. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041540311 · Cited by 70
Novel Mutations in K13 Propeller Gene of Artemisinin-ResistantPlasmodium falciparum
Isozumi, R., Uemura, H., Kimata, I., Ichinose, Y., Logedi, J., Omar, A. H., & Kaneko, A. (2015) · Emerging infectious diseases · doi:10.3201/eid2103.140898 · Cited by 70
Cooper, R. A., Conrad, M. D., Watson, Q. D., Huezo, S. J., Ninsiima, H., Tumwebaze, P. K., Nsobya, S. L., & Rosenthal, P. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00921-15 · Cited by 68
Plasmodium Falciparum Resistant to Chloroquine in Cambodia
Eyles, D. E., Hoo, C. C., Warren, M., et al. (1963) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1963.12.840 · Cited by 64
Slow Clearance ofPlasmodium falciparumin Severe Pediatric Malaria, Uganda, 2011–2013
Hawkes, M., Conroy, A. L., Opoka, R. O., Namasopo, S., Zhong, K., Liles, W. C., John, C. C., & Kain, K. C. (2015) · Emerging infectious diseases · doi:10.3201/eid2107.150213 · Cited by 63
Das, D., Tripura, R., Phyo, A. P., Lwin, K. M., Tärning, J., Lee, S. J., Hanpithakpong, W., Stepniewska, K., Ménard, D., Ringwald, P., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis958 · Cited by 60
Self-citationBethell, D., Se, Y., Lon, C., Socheat, D., Saunders, D., Teja‐Isavadharm, P., Khemawoot, P., Sea, D., Lin, J. T., Sriwichai, S., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/657402 · Cited by 57
Leang, R., Canavati, S. E., Khim, N., Vestergaard, L. S., Borghini-Fuhrer, I., Kim, S., Denis, M. B., Heng, P., Tol, B., Huy, R., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-16 · Cited by 56
Self-citationReal-time PCR methods for monitoring antimalarial drug resistance
Wilson, P. E., Alker, A. P., & Meshnick, S. R. (2005) · Trends in Parasitology · doi:10.1016/j.pt.2005.04.007 · Cited by 53
Human ex vivo studies on asexual Plasmodium vivax: The best way forward
Russell, B., Suwanarusk, R., Malleret, B., Costa, F. T. M., Snounou, G., Baird, J. K., Nosten, F. H., & Rénia, L. (2012) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.08.010 · Cited by 52
Factors Determining Water Treatment Behavior for the Prevention of Cholera in Chad
Lilje, J., Kessely, H., & Mosler, H. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0613 · Cited by 51
Musset, L., Bras, J. L., & Clain, J. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm087 · Cited by 50
Woodrow, C. J., Dahlström, S., Cooksey, R., Flegg, J. A., Nagard, H. L., Mentré, F., Murillo, C., Ménard, D., Nosten, F. H., Sriprawat, K., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02350-12 · Cited by 47
Ngum, W. P., Hastings, I. M., Dondorp, A. M., White, L. J., Maude, R. J., Saralamba, S., Day, N., White, N. J., & Boni, M. F. (2009) · Evolutionary Applications · doi:10.1111/j.1752-4571.2008.00067.x · Cited by 45
Self-citationRingwald, P., Ekobo, A. S., Keundjian, A., Mangamba, D. K. K., & Basco, L. K. (2000) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2000.00613.x · Cited by 40
Evolution from double to triple-antimalarial drug combinations
Shanks, G. D., Edstein, M. D., & Jacobus, D. P. (2014) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/tru199 · Cited by 37
Shaw, P. J., Chaotheing, S., Kaewprommal, P., Piriyapongsa, J., Wongsombat, C., Suwannakitti, N., Koonyosying, P., Uthaipibull, C., Yuthavong, Y., & Kamchonwongpaisan, S. (2015) · BMC Genomics · doi:10.1186/s12864-015-2040-0 · Cited by 37
Pattanapanyasat, K., Thaithong, S., Kyle, D. E., Udomsangpetch, R., Yongvanitchit, K., Hider, R. C., & Webster, H. K. (1997) · Cytometry · Cited by 34
Lim, P., Dek, D., Try, V., Sreng, S., Suon, S., & Fairhurst, R. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05163-14 · Cited by 34
Kloprogge, F., McGready, R. M., Phyo, A. P., Rijken, M. J., Hanpithakpon, W., Than, H. H., Hlaing, N., Zin, N. T., Day, N., White, N. J., et al. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12660 · Cited by 33
Gupta, B., Xu, S., Wang, Z., Sun, L., Miao, J., Cui, L., & Yang, Z. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku125 · Cited by 32
Towards real-time monitoring of artemisinin resistance
Ménard, D., & Ariey, F. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70046-0 · Cited by 21
Nuralitha, S., Siregar, J. E., Syafruddin, D., Roelands, J. P., Verhoef, J., Hoepelman, A. I. M., & Marzuki, S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00538-15 · Cited by 11
Approaches to Malaria Vaccine Development Using the Retrospectroscope
Sardá, V., Kaslow, D. C., & Williamson, K. C. (2009) · Infection and Immunity · doi:10.1128/iai.00122-09 · Cited by 11
Cited by
Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria
Wicht, K. J., Mok, S., & Fidock, D. A. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115546 · Cited by 322
Varo, R., Chaccour, C., & Bassat, Q. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.05.024 · Cited by 31
Kayiba, N. K., Yobi, D. M., Tchakounang, V. R. K., Mvumbi, D. M., Kabututu, P. Z., Devleesschauwer, B., Mukomena, E. S., DeMol, P., Hayette, M.-P., Mvumbi, G. L., et al. (2021) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2021.105009 · Cited by 22
Metadata
- Authors
- Menard, D., & Dondorp, A.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-03-13
- Volume
- 7
- Issue
- 7
- Pages
- a025619
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2597145668
- Cited by
- 499
- References
- 107
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.